Zentalis Pharmaceuticals, Inc. (ZNTL) › Net IncomeZentalis Pharmaceuticals, Inc. (ZNTL) — Net IncomeAnnual figures by fiscal year, from SEC filings.2019: -$45.66M2020: -$117.84M2021: -$158.72M2022: -$236.81M2023: -$292.19M2024: -$165.84M2025: -$137.06M-$137.06M2019Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$137.06M+17.4%2024-$165.84M+43.2%2023-$292.19M-23.4%2022-$236.81M-49.2%2021-$158.72M-34.7%2020-$117.84M-158.1%2019-$45.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share